N-acetylcysteine ameliorates acute kidney injury but not glomerular hemorrhage in an animal model of warfarin-related nephropathy

American Journal of Physiology - Renal Physiology

Volumn 304, Issue 12, 2013, Pages 1421-1427

  Ware, Kyle ^a   Qamri, Zahida ^a   Ozcan, Ayhan ^a,c   Satoskar, Anjali A ^a   Nadasdy, Gyongyi ^a   Rovin, Brad H ^b   Hebert, Lee A ^b   Nadasdy, Tibor ^a   Brodsky, Sergey V ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^c GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

5 6 nephrectomy; Oxidative stress; Warfarin related nephropathy

Indexed keywords

ACETYLCYSTEINE; DEFEROXAMINE; WARFARIN;

ABLATION THERAPY; ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICOAGULATION; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ERYTHROCYTE; GLOMERULAR HEMORRHAGE; GLOMERULOPATHY; HEMATURIA; IRON CHELATION; KIDNEY FUNCTION; KIDNEY TUBULE CELL; MALE; NEPHRECTOMY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTHROMBIN TIME; RAT; RENAL ARTERY; REPERFUSION INJURY; UNINEPHRECTOMY;

EID: 84879169619     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00689.2012     Document Type: Article

References (42)

1. Arfsten DP, Johnson EW, Wilfong ER, Jung AE, Bobb AJ. Distribution of radio-labeled N-Acetyl-L-Cysteine in Sprague-Dawley rats and its effect on glutathione metabolism following single and repeat dosing by oral gavage. Cutan Ocul Toxicol 26: 113-134, 2007.
2. Baliga R, Zhang Z, Baliga M, Ueda N, Shah SV. In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity. Kidney Int 53: 394-401, 1998.
3. Ballarin J, Arce Y, Torra Balcells R, Diaz Encarnacion M, Manzar-beitia F, Ortiz A, Egido J, Moreno JA. Acute renal failure associated to paroxysmal nocturnal haemoglobinuria leads to intratubular haemosiderin accumulation and CD163 expression. Nephrol Dial Transplant 26: 3408-3411, 2011.
4. Barbey MM, Fels LM, Soose M, Poelstra K, Gwinner W, Bakker W, Stolte H. Adriamycin affects glomerular renal function: evidence for the involvement of oxygen radicals. Free Radic Res Commun 7: 195-203, 1989.
5. Brodsky SV, Collins M, Park E, Rovin BH, Satoskar AA, Nadasdy G, Wu H, Bhatt U, Nadasdy T, Hebert LA. Warfarin therapy that results in an International Normalization Ratio above the therapeutic range is associated with accelerated progression of chronic kidney disease. Nephron Clin Pract 115: c142-c146, 2010.
6. Brodsky SV, Nadasdy T, Rovin BH, Satoskar AA, Nadasdy GM, Wu HM, Bhatt UY, Hebert LA. Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate. Kidney Int 80: 181-189, 2011.
7. Brodsky SV, Satoskar A, Chen J, Nadasdy G, Eagen JW, Hamirani M, Hebert L, Calomeni E, Nadasdy T. Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases. Am J Kidney Dis 54: 1121-1126, 2009.
8. Brodsky SV, Yamamoto T, Tada T, Kim B, Chen J, Kajiya F, Goligorsky MS. Endothelial dysfunction in ischemic acute renal failure: rescue by transplanted endothelial cells. Am J Physiol Renal Physiol 282: F1140-F1149, 2002.
9. Cachofeiro V, Goicochea M, de Vinuesa SG, Oubina P, Lahera V, Luno J. Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease. Kidney Int Suppl 111: S4-S9, 2008.
10. Campos R, Shimizu MH, Volpini RA, de Braganca AC, Andrade L, Lopes FD, Olivo C, Canale D, Seguro AC. N-acetylcysteine prevents pulmonary edema and acute kidney injury in rats with sepsis submitted to mechanical ventilation. Am J Physiol Lung Cell Mol Physiol 302: L640- L650, 2012.
11. Care CftUotGft Animals UoL, Council NR. Guide for the Care and Use of Laboratory Animals: Eighth Edition. The National Academies, 2011.
12. Crawford A, Fassett RG, Coombes JS, Kunde DA, Ahuja KD, Robertson IK, Ball MJ, Geraghty DP. Relationship between antioxidant enzyme genotype and activity and kidney function: a case-control study. Clin Nephrol 78: 135-144, 2012.
13. Diez-Sampedro A, Lenz O, Fornoni A. Podocytopathy in diabetes: a metabolic and endocrine disorder. Am J Kidney Dis 58: 637-646, 2011.
14. DiMari J, Megyesi J, Udvarhelyi N, Price P, Davis R, Safirstein R. N-acetyl cysteine ameliorates ischemic renal failure. Am J Physiol Renal Physiol 272: F292-F298, 1997.
15. Duann P, Datta PK, Pan C, Blumberg JB, Sharma M, Lianos EA. Superoxide dismutase mimetic preserves the glomerular capillary permeability barrier to protein. J Pharmacol Exp Ther 316: 1249-1254, 2006.
16. Fukuda A, Wickman LT, Venkatareddy MP, Sato Y, Chowdhury MA, Wang SQ, Shedden KA, Dysko RC, Wiggins JE, Wiggins RC. Angiotensin II-dependent persistent podocyte loss from destabilized glom-eruli causes progression of end stage kidney disease. Kidney Int 81: 40-55, 2012.
17. Guru V, Fremes SE. The role of N-acetylcysteine in preventing radio-graphic contrast-induced nephropathy. Clin Nephrol 62: 77-83, 2004.
18. Hahn S, Krieg RJ Jr, Hisano S, Chan W, Kuemmerle NB, Saborio P, Chan JC. Vitamin E suppresses oxidative stress and glomerulosclerosis in rat remnant kidney. Pediatr Nephrol 13: 195-198, 1999.
19. Homsi E, Janino P, de Faria JB. Role of caspases on cell death, inflammation, and cell cycle in glycerol-induced acute renal failure. Kidney Int 69: 1385-1392, 2006.
20. Hostetter TH. Hyperfiltration and glomerulosclerosis. Semin Nephrol 23: 194-199, 2003.
21. Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol Renal Fluid Electrolyte Physiol 241: F85-F93, 1981.
22. Hsu SP, Chiang CK, Yang SY, Chien CT. N-acetylcysteine for the management of anemia and oxidative stress in hemodialysis patients. Nephron Clin Pract 116: c207-c216, 2010.
23. Johns EJ, O'Shaughnessy B, O'Neill S, Lane B, Healy V. Impact of elevated dietary sodium intake on NAD(P)H oxidase and SOD in the cortex and medulla of the rat kidney. Am J Physiol Regul Integr Comp Physiol 299: R234-R240, 2010.
24. Levine RL, Williams JA, Stadtman ER, Shacter E. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 233: 346-357, 1994.
25. Martin Cleary C, Moreno JA, Fernandez B, Ortiz A, Parra EG, Gracia C, Blanco-Colio LM, Barat A, Egido J. Glomerular haematuria, renal interstitial haemorrhage and acute kidney injury. Nephrol Dial Transplant 25: 4103-4106, 2010.
26. Massy ZA, Stenvinkel P, Drueke TB. The role of oxidative stress in chronic kidney disease. Semin Dial 22: 405-408, 2009.
27. Mayer G, Lafayette RA, Oliver J, Deen WM, Myers BD, Meyer TW. Effects of angiotensin II receptor blockade on remnant glomerular perm-selectivity. Kidney Int 43: 346-353, 1993.
28. Molina-Jijon E, Zarco-Marquez G, Medina-Campos ON, Zatarain-Barron ZL, Hernandez-Pando R, Pinzon E, Zavaleta RM, Tapia E, Pedraza-Chaverri J. Deferoxamine pretreatment prevents Cr(VI)-in-duced nephrotoxicity and oxidant stress: role of Cr(VI) chelation. Toxicology 291: 93-101, 2012.
29. Nitescu N, Ricksten SE, Marcussen N, Haraldsson B, Nilsson U, Basu S, Guron G. N-acetylcysteine attenuates kidney injury in rats subjected to renal ischaemia-reperfusion. Nephrol Dial Transplant 21: 1240 -1247, 2006.
30. Nolin TD, Ouseph R, Himmelfarb J, McMenamin ME, Ward RA. Multiple-dose pharmacokinetics and pharmacodynamics of N-acetylcys-teine in patients with end-stage renal disease. Clin J Am Soc Nephrol 5: 1588-1594, 2010.
31. Ozcan A, Ware K, Calomeni E, Nadasdy T, Forbes R, Satoskar AA, Nadasdy G, Rovin BH, Hebert LA, Brodsky SV. 5/6 Nephrectomy as a validated rat model mimicking human warfarin-related nephropathy. Am J Nephrol 35: 356-364, 2012.
32. Patel RP, Svistunenko DA, Darley-Usmar VM, Symons MC, Wilson MT. Redox cycling of human methaemoglobin by H2O2 yields persistent ferryl iron and protein based radicals. Free Radic Res 25: 117-123, 1996.
33. Sharma M, McCarthy ET, Savin VJ, Lianos EA. Nitric oxide preserves the glomerular protein permeability barrier by antagonizing superoxide. Kidney Int 68: 2735-2744, 2005.
34. Sharma R, Sharma M, Datta PK, Savin VJ. Induction of metallothio-nein-I protects glomeruli from superoxide-mediated increase in albumin permeability. Exp Biol Med (Maywood) 227: 26-31, 2002.
35. Shavit L, Korenfeld R, Lifschitz M, Butnaru A, Slotki I. Sodium bicarbonate versus sodium chloride and oral N-acetylcysteine for the prevention of contrast-induced nephropathy in advanced chronic kidney disease. J Interv Cardiol 22: 556-563, 2009.
36. Shimizu MH, Danilovic A, Andrade L, Volpini RA, Liborio AB, Sanches TR, Seguro AC. N-acetylcysteine protects against renal injury following bilateral ureteral obstruction. Nephrol Dial Transplant 23: 3067-3073, 2008.
37. Stadtman ER, Oliver CN. Metal-catalyzed oxidation of proteins. Physiological consequences. J Biol Chem 266: 2005-2008, 1991.
38. Tain YL, Freshour G, Dikalova A, Griendling K, Baylis C. Vitamin E reduces glomerulosclerosis, restores renal neuronal NOS, and suppresses oxidative stress in the 5/6 nephrectomized rat. Am J Physiol Renal Physiol 292: F1404-F1410, 2007.
39. Tracz MJ, Alam J, Nath KA. Physiology and pathophysiology of heme: implications for kidney disease. J Am Soc Nephrol 18: 414-420, 2007.
40. Tsiftsoglou AS, Tsamadou AI, Papadopoulou LC. Heme as key regulator of major mammalian cellular functions: molecular, cellular, and pharmacological aspects. Pharmacol Ther 111: 327-345, 2006.
41. Ware K, Brodsky P, Satoskar AA, Nadasdy T, Nadasdy G, Wu H, Rovin BH, Bhatt U, Von Visger J, Hebert LA, Brodsky SV. Warfarin-related nephropathy modeled by nephron reduction and excessive antico-agulation. J Am Soc Nephrol 22: 1856-1862, 2011.
42. Ziyadeh FN, Wolf G. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy. Curr Diabetes Rev 4: 39-45, 2008.